• BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value Seeking Alpha Sun, 04 May 2025 12:00:02 GMT

• stocknews.com begins coverage on biolinerx (nasdaq:blrx) Defense World Fri, 02 May 2025 06:10:29 GMT

• biolinerx announces pricing of $15.4 million underwritten public offering of its american depositary shares and warrants | libero ... Libero Quotidiano Fri, 25 Apr 2025 09:00:53 GMT

• biolinerx announces closing of $15.4 million underwritten public offering of its american depositary shares and warrants | libero ... Libero Quotidiano Mon, 21 Apr 2025 15:40:59 GMT

• BioLineRx (NASDAQ:BLRX) Earns Hold Rating from Jones Trading Defense World Fri, 04 Apr 2025 07:00:00 GMT

• FY2025 EPS Estimates for BioLineRx Boosted by HC Wainwright Defense World Fri, 04 Apr 2025 07:00:00 GMT

• BLRX: 2024 Financial Results MSN Thu, 03 Apr 2025 14:30:05 GMT

• Research Analysts Issue Forecasts for BioLineRx Q1 Earnings Defense World Thu, 03 Apr 2025 07:00:00 GMT

• biolinerx stock rating cut to hold at jones trading by investing.com Investing.com Australia Wed, 02 Apr 2025 09:44:48 GMT

• biolinerx downgraded to hold from buy at jonesresearch TipRanks Tue, 01 Apr 2025 20:47:36 GMT

• BioLineRx Ltd. (NASDAQ:BLRX) Q4 2024 Earnings Call Transcript Insider Monkey Tue, 01 Apr 2025 07:00:00 GMT

• BLRX stock touches 52-week low at $2.85 amid sharp annual decline Investing.com Tue, 01 Apr 2025 07:00:00 GMT

• biolinerx (nasdaq:blrx) price target raised to $26.00 at hc wainwright Defense World Tue, 01 Apr 2025 07:00:00 GMT

• biolinerx stock rating cut to hold at jones trading Investing.com Tue, 01 Apr 2025 07:00:00 GMT

• h.c. wainwright raises biolinerx stock target to $26 Investing.com Tue, 01 Apr 2025 07:00:00 GMT

• biolinerx ltd. reports 2024 financial results and strategic progress TipRanks Tue, 01 Apr 2025 04:56:31 GMT

• biolinerx earnings call: strategic shifts and growth TipRanks Tue, 01 Apr 2025 00:07:25 GMT

• biolinerx price target adjusted to $26 at h.c. wainwright after reverse split TipRanks Mon, 31 Mar 2025 19:33:13 GMT

• BioLineRx Reports 2024 Financial Results and Provides Corporate Update PR Newswire Mon, 31 Mar 2025 07:00:00 GMT

• BioLineRx Reports Strong 2024 Financial Results and Strategic Advancements TipRanks Mon, 31 Mar 2025 07:00:00 GMT

• BioLineRx to Report 2024 Annual Results on March 31, 2025 PR Newswire Mon, 31 Mar 2025 07:00:00 GMT

• BioLineRx Earnings Call: Strategic Shifts and Growth TipRanks Mon, 31 Mar 2025 07:00:00 GMT

• BioLineRx Ltd. Reports 2024 Financial Results and Strategic Progress TipRanks Mon, 31 Mar 2025 07:00:00 GMT

• BioLineRx Ltd. (NASDAQ:BLRX) Q4 2024 Earnings Call Transcript MSN Mon, 31 Mar 2025 07:00:00 GMT

• Clinical-Stage Biotech BioLineRx Sets Date for 2024 Annual Results: CEO Briefing Announced Stock Titan Mon, 24 Mar 2025 07:00:00 GMT

• biolinerx to report 2024 annual results on march 31, 2025 Yahoo Finance Mon, 24 Mar 2025 07:00:00 GMT

• biolinerx (nasdaq:blrx) stock rating lowered by stocknews.com The AM Reporter Thu, 20 Mar 2025 07:00:00 GMT

• biolinerx (nasdaq:blrx) downgraded by stocknews.com to “sell” Defense World Wed, 19 Mar 2025 07:00:00 GMT

• biolinerx (blrx) projected to post earnings on tuesday Defense World Tue, 18 Mar 2025 06:00:06 GMT

• biolinerx ltd. (nasdaq:blrx) sees significant increase in short interest Defense World Sun, 02 Mar 2025 08:00:00 GMT

• biolinerx announces strategic shift with licensing deals MSN Wed, 26 Feb 2025 02:40:51 GMT

• biolinerx to report second quarter 2024 results on august 15, 2024 Marketscreener.com Thu, 20 Feb 2025 03:30:09 GMT

• biolinerx stock hits 52-week low at $3.24 amid sharp decline MSN Wed, 19 Feb 2025 08:36:10 GMT

• blrx: aphexda transition progressing Yahoo Finance Wed, 19 Feb 2025 08:00:00 GMT

• stocknews.com initiates coverage on biolinerx (nasdaq:blrx) Defense World Tue, 04 Feb 2025 08:03:50 GMT

• biolinerx stock hits 52-week low at $3.24 amid sharp decline Investing.com Australia Sat, 01 Feb 2025 08:00:00 GMT

• BioLineRx stock hits 52-week low at $3.24 amid sharp decline Investing.com Fri, 31 Jan 2025 08:00:00 GMT

• stocknews.com initiates coverage on biolinerx (nasdaq:blrx) Defense World Mon, 27 Jan 2025 08:00:00 GMT

• biolinerx announces strategic shift with licensing deals MSN Thu, 23 Jan 2025 00:41:31 GMT

• biolinerx issues letter to shareholders – company announcement Financial Times Tue, 21 Jan 2025 12:00:00 GMT

• BioLineRx Issues Letter to Shareholders PR Newswire Tue, 21 Jan 2025 08:00:00 GMT

• BioLineRx announces strategic shift with licensing deals Investing.com Tue, 21 Jan 2025 08:00:00 GMT

• biolinerx secures $25m upfront in major licensing deals, extends cash runway to 2026 Stock Titan Tue, 21 Jan 2025 08:00:00 GMT

• biolinerx outlines strategic vision and financial outlook after key licensing deals TipRanks Tue, 21 Jan 2025 08:00:00 GMT

• biolinerx says current cash to provide runway through 2h26 TipRanks Tue, 21 Jan 2025 08:00:00 GMT

• biolinerx announces change to ratio of ads to ordinary shares MSN Tue, 21 Jan 2025 03:18:16 GMT

• biolinerx (nasdaq:blrx) earns hold rating from analysts at stocknews.com Defense World Sun, 19 Jan 2025 08:00:00 GMT

• biolinerx announces change to ratio of ads to ordinary shares MSN Sat, 18 Jan 2025 14:29:47 GMT

• biolinerx (nasdaq:blrx) shares set to reverse split on thursday, january 30th Defense World Sat, 18 Jan 2025 08:00:00 GMT

• biolinerx announces change to ratio of ads to ordinary shares MSN Fri, 17 Jan 2025 13:11:14 GMT

• BioLineRx Announces 1:40 ADS Ratio Change, Confirms $29.5M Cash Runway Through 2026 Stock Titan Fri, 17 Jan 2025 08:00:00 GMT

• BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares PR Newswire Fri, 17 Jan 2025 08:00:00 GMT

• BioLineRx Adjusts ADS Ratio to Maintain Nasdaq Listing TipRanks Fri, 17 Jan 2025 08:00:00 GMT

• biolinerx stock touches 52-week low at $0.14 amid downturn Investing.com Mon, 13 Jan 2025 08:00:00 GMT

• biolinerx (nasdaq:blrx) coverage initiated by analysts at stocknews.com Defense World Sat, 11 Jan 2025 07:18:41 GMT

• biolinerx announces $10 million registered direct offering The Malaysian Reserve Tue, 07 Jan 2025 08:38:15 GMT

• BiolineRx Announces Major Direct Offering to Bolster Operations TipRanks Tue, 07 Jan 2025 08:00:00 GMT

• biolinerx announces $10m registered direct offering; shares tumble MSN Tue, 07 Jan 2025 08:00:00 GMT

• biolinerx stock plunges to 52-week low of $0.19 amid market challenges Investing.com Australia Tue, 07 Jan 2025 08:00:00 GMT

• biolinerx announces $10m registered direct offering; shares tumble MSN Mon, 06 Jan 2025 14:48:47 GMT

• BioLineRx Raises $10M in Direct Offering at $0.20 Per ADS with Matching Warrants Stock Titan Mon, 06 Jan 2025 08:00:00 GMT

• BioLineRx Announces $10 Million Registered Direct Offering PR Newswire Mon, 06 Jan 2025 08:00:00 GMT

• BioLineRx Announces $10 Million Direct Offering to Fuel Growth TipRanks Mon, 06 Jan 2025 08:00:00 GMT

• Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet Benzinga Mon, 06 Jan 2025 08:00:00 GMT

• biolinerx stock plunges to 52-week low of $0.19 amid market challenges Investing.com Mon, 06 Jan 2025 08:00:00 GMT

• biotech alert: searches spiking for these stocks today TipRanks Mon, 06 Jan 2025 08:00:00 GMT

• biolinerx (nasdaq:blrx) now covered by stocknews.com Defense World Fri, 03 Jan 2025 08:00:00 GMT

• stocknews.com begins coverage on biolinerx (nasdaq:blrx) Defense World Thu, 26 Dec 2024 08:00:00 GMT

• biolinerx (nasdaq:blrx) now covered by stocknews.com Defense World Wed, 18 Dec 2024 18:39:28 GMT

• biolinerx stock hits 52-week low at $0.21 amid market challenges Investing.com Mon, 16 Dec 2024 08:00:00 GMT

• biolinerx to report third quarter 2024 results on november 25, 2024 Longview News-Journal Sun, 08 Dec 2024 01:12:17 GMT

• biolinerx to report third quarter 2024 results on november 25, 2024 Kilgore News Herald Sat, 07 Dec 2024 18:17:27 GMT

• biolinerx stock plunges to 52-week low, hits $0.25 by investing.com Investing.com Canada Sat, 07 Dec 2024 09:50:23 GMT

• biolinerx stock plunges to 52-week low, hits $0.25 Investing.com Fri, 06 Dec 2024 08:00:00 GMT

• blrx: ayrmid assumes commercialization efforts Smartkarma Wed, 04 Dec 2024 08:00:00 GMT

• blrx: ayrmid assumes commercialization efforts Smartkarma Tue, 03 Dec 2024 22:25:17 GMT

• biolinerx stock jumps 14% on st. jude clinical trial for mitoxafortide MSN Sat, 30 Nov 2024 08:01:00 GMT

• biolinerx: update on lead programs Investing.com Fri, 29 Nov 2024 03:42:14 GMT

• blrx - biolinerx ltd latest stock news & market updates StockTitan Tue, 26 Nov 2024 08:59:35 GMT

• biolinerx ltd. (nasdaq:blrx) q3 2024 earnings call transcript Insider Monkey Tue, 26 Nov 2024 08:00:00 GMT

• biolinerx stock target cut, retains buy on q3 financial results Investing.com Tue, 26 Nov 2024 08:00:00 GMT

• biolinerx reports strategic moves in q3 2024 TipRanks Tue, 26 Nov 2024 03:59:40 GMT

• biolinerx reports third quarter 2024 financial results and provides update on transformation to drive shareholder value PR Newswire Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx price target lowered to $9 from $21 at h.c. wainwright Nasdaq Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx reports q3 eps 0c vs. (2c) last year TipRanks Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx secures key deals to boost shareholder value TipRanks Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx reports strategic moves in q3 2024 TipRanks Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx inks $97m licensing deal, secures $9m investment amid q3 results StockTitan Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx to report third quarter 2024 results on november 25, 2024 PR Newswire Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx earnings beat by $0.04, revenue topped estimates Investing.com Nigeria Mon, 25 Nov 2024 08:00:00 GMT

• earnings call: biolinerx announces q3 results and strategic shifts Investing.com Mon, 25 Nov 2024 08:00:00 GMT

• biolinerx q3 2024 earnings preview MSN Sun, 24 Nov 2024 01:47:59 GMT

• biolinerx to report third quarter 2024 results on november 25, 2 GuruFocus.com Sat, 23 Nov 2024 22:27:27 GMT

• biolinerx inks licensing deal, share purchase agreement MSN Fri, 22 Nov 2024 13:35:27 GMT

• BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell Yahoo Finance Fri, 22 Nov 2024 08:00:00 GMT

• biolinerx stock hits 52-week low at $0.38 amid market challenges Investing.com Australia Fri, 22 Nov 2024 08:00:00 GMT

• biolinerx announces uspto allowance of new composition of matter patent on motixafortide GuruFocus.com Fri, 22 Nov 2024 00:53:27 GMT

• biolinerx, ayrmid enter license agreement for motixafortide through gamida cell TipRanks Thu, 21 Nov 2024 12:38:54 GMT

• biolinerx ltd. and biolinerx usa, inc announces stepdown of holly may as president Marketscreener.com Thu, 21 Nov 2024 11:50:00 GMT

• sec form 424b5 filed by biolinerx ltd. Quantisnow Thu, 21 Nov 2024 11:44:40 GMT

• blrx - biolinerx ltd latest stock news & market updates StockTitan Thu, 21 Nov 2024 11:30:00 GMT

• BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd... PR Newswire Thu, 21 Nov 2024 08:00:00 GMT

• biolinerx stock sinks on share purchase deal (blrx:nasdaq) Seeking Alpha Thu, 21 Nov 2024 08:00:00 GMT

• biolinerx stock hits 52-week low at $0.38 amid market challenges Investing.com Thu, 21 Nov 2024 08:00:00 GMT

• biolinerx ltd. announces new direct offering of shares TipRanks Thu, 21 Nov 2024 08:00:00 GMT

• biolinerx lands $10m deal with ayrmid for aphexda, plus $87m in milestone potential StockTitan Thu, 21 Nov 2024 08:00:00 GMT

• amended: biolinerx inks license agreement with ayrmid to commercialize aphexda Nasdaq Thu, 21 Nov 2024 08:00:00 GMT

• BioLineRx to Report Third Quarter 2024 Results on November 25, 2024 Yahoo Finance Wed, 20 Nov 2024 08:00:00 GMT

• biolinerx to report q3 2024 financial results on november 25 StockTitan Wed, 20 Nov 2024 08:00:00 GMT

• more stem cells for sickle cell gene therapy readied with motixafortide Sickle Cell Disease News Thu, 14 Nov 2024 08:00:00 GMT

• BioLineRx Granted Extension to Meet Nasdaq Requirements Nasdaq Tue, 12 Nov 2024 08:00:00 GMT

• hc wainwright reiterates buy rating for biolinerx (nasdaq:blrx) Defense World Sun, 10 Nov 2024 07:09:22 GMT

• BioLineRx Announces Oral Presentation on Data from Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Ce... PR Newswire Tue, 05 Nov 2024 08:00:00 GMT

• biolinerx’s motixafortide shows promise in sickle cell trials TipRanks Tue, 05 Nov 2024 08:00:00 GMT

• biolinerx's motixafortide shows 3.2x better stem cell mobilization in breakthrough scd trial | blrx stock news StockTitan Tue, 05 Nov 2024 08:00:00 GMT

• biolinerx stock hits 52-week low at $0.39 amid market challenges Investing.com Thu, 24 Oct 2024 07:00:00 GMT

• biolinerx receives uspto allowance of new composition of matter patent on motixafortide MSN Mon, 21 Oct 2024 03:33:13 GMT

• biolinerx initiates phase 1b/2 trial for bl-8040 in gastric cancer under immunotherapy collaboration Reuters Fri, 18 Oct 2024 07:00:00 GMT

• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com India Thu, 17 Oct 2024 05:15:20 GMT

• biolinerx to present at 2013 annual jmp securities healthcare conference in new york AOL Wed, 16 Oct 2024 13:32:04 GMT

• biolinerx ltd. announces uspto allowance of new composition of matter patent on motixafortide Marketscreener.com Wed, 16 Oct 2024 11:09:00 GMT

• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com Nigeria Wed, 16 Oct 2024 10:18:29 GMT

• biolinerx announces uspto allowance of new composition of matter patent on motixafortide Yahoo Finance Wed, 16 Oct 2024 07:00:00 GMT

• biolinerx secures us patent for cancer drug motixafortide Investing.com Wed, 16 Oct 2024 07:00:00 GMT

• biolinerx secures extended u.s. patent for motixafortide TipRanks Wed, 16 Oct 2024 07:00:00 GMT

• biolinerx receives notification of allowance from uspto for motixafortide TipRanks Wed, 16 Oct 2024 07:00:00 GMT

• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com Tue, 15 Oct 2024 07:00:00 GMT

• biolinerx (nasdaq:blrx) research coverage started at stocknews.com Defense World Tue, 15 Oct 2024 06:29:20 GMT

• biolinerx stock hits 52-week low at $0.5 amid market challenges Investing.com Thu, 03 Oct 2024 00:30:41 GMT

• biolinerx stock hits 52-week low at $0.5 amid market challenges Investing.com Wed, 02 Oct 2024 07:00:00 GMT

• biolinerx ltd. shareholders approve key resolutions TipRanks Tue, 01 Oct 2024 07:00:00 GMT

• biolinerx announces initiation of phase 1b/2 trial for bl-8040 in aml under immunotherapy collaboration Reuters Thu, 26 Sep 2024 07:00:00 GMT

• biolife solutions (nasdaq:blfs) shares down 2% Defense World Thu, 19 Sep 2024 13:33:53 GMT

• biolife solutions, inc. (nasdaq:blfs) cro garrie richardson sells 3,070 shares Defense World Wed, 18 Sep 2024 22:39:10 GMT

• bionexus gene lab corp. (nasdaq:bglc) short interest update Defense World Wed, 18 Sep 2024 20:57:56 GMT

• biolinerxl launches digital resource for mm patients ‘mobilization matters’ TipRanks Tue, 17 Sep 2024 17:45:58 GMT

• bionexus gene lab corp (bglc) stock: a year of market fluctuations The InvestChronicle Tue, 17 Sep 2024 17:11:34 GMT

• BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection PR Newswire Tue, 17 Sep 2024 07:00:00 GMT

• reviewing biolargo (nasdaq:blgo) and loop industries (nasdaq:loop) Defense World Tue, 17 Sep 2024 05:44:08 GMT

• biolinerx stock jumps 14% on st. jude clinical trial for mitoxafortide MSN Mon, 16 Sep 2024 18:49:06 GMT

• there is no way bionexus gene lab corp (bglc) can keep these numbers up SETE News Mon, 16 Sep 2024 11:11:36 GMT

• biolinerx shares initiated with buy rating, $2 target Investing.com Wed, 04 Sep 2024 03:03:04 GMT

• biolinerx initiated with a buy at jonesresearch TipRanks Tue, 03 Sep 2024 20:57:50 GMT

• biolinerx ltd receives investment bank analyst rating update by investing.com Investing.com UK Tue, 03 Sep 2024 07:00:00 GMT

• biolinerx shares initiated with buy rating, $2 target Investing.com Tue, 03 Sep 2024 07:00:00 GMT

• seborrheic keratosis treatment market report 2024-2030, GlobeNewswire Thu, 29 Aug 2024 04:16:23 GMT

• Seborrheic Keratosis Treatment Market Report 2024-2030, GlobeNewswire Wed, 28 Aug 2024 07:00:00 GMT

• equities analysts issue forecasts for biolinerx ltd.'s fy2024 earnings (nasdaq:blrx) MarketBeat Thu, 22 Aug 2024 12:12:21 GMT

• fy2024 earnings forecast for biolinerx ltd. issued by zacks small cap (nasdaq:blrx) MarketBeat Thu, 22 Aug 2024 07:00:00 GMT

• BLRX: On Track for 60% Formulary Placement Yahoo Finance Tue, 20 Aug 2024 07:00:00 GMT

BioLineRx Ltd
(NASDAQ:BLRX)

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134...

Website: http://www.biolinerx.com

Founded: 2003

Full Time Employees: 42

Sector: Healthcare

Industry: Biotechnology

Pharmaceuticals

Share this website to your friends

BioLineRx Ltd(NASDAQ:BLRX)

BioLineRx Ltd
(NASDAQ:BLRX)